深层前锯肌平面阻滞对老年胸科病人手术应激和术后认知功能障碍的影响

注册号:

Registration number:

ChiCTR2300068717 

最近更新日期:

Date of Last Refreshed on:

2023-07-22 20:08:26 

注册时间:

Date of Registration:

2023-02-28 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

深层前锯肌平面阻滞对老年胸科病人手术应激和术后认知功能障碍的影响

Public title:

Effect of deep anterior serratus plane block on operative stress and postoperative cognitive dysfunction in elderly thoracic patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

深层前锯肌平面阻滞对老年胸科病人手术应激和术后认知功能障碍的影响

Scientific title:

Effect of deep anterior serratus plane block on operative stress and postoperative cognitive dysfunction in elderly thoracic patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

程佳婷 

研究负责人:

程远 

Applicant:

Jiating Cheng 

Study leader:

Yuan Cheng 

申请注册联系人电话:

Applicant telephone:

+86 188 9538 1896

研究负责人电话:

Study leader's
telephone:

+86 138 0652 2883

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

459190330@qq.com

研究负责人电子邮件:

Study leader's E-mail:

13806552283@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省杭州市上城区浣纱路261号

研究负责人通讯地址:

浙江省杭州市上城区浣纱路261号

Applicant address:

261 Huansha Road, Shangcheng District, Hangzhou, Zhejiang

Study leader's address:

261 Huansha Road, Shangcheng District, Hangzhou, Zhejiang

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

温州医科大学

Applicant's institution:

Wenzhou Medical University

研究负责人所在单位:

杭州市第一人民医院

Affiliation of the Leader:

Hangzhou First People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

【2020】医伦审第(050)号-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

杭州市第一人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Hangzhou First People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020-11-20 00:00:00

伦理委员会联系人:

翟先国

Contact Name of the ethic committee:

Xianguo Zhai

伦理委员会联系地址:

浙江省杭州市上城区浣纱路261号

Contact Address of the ethic committee:

261 Huansha Road, Shangcheng District, Hangzhou, Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 571 5600 7429

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

杭州市第一人民医院

Primary sponsor:

Hangzhou First People's Hospital

研究实施负责(组长)单位地址:

浙江省杭州市上城区浣纱路261号

Primary sponsor's address:

261 Huansha Road, Shangcheng District, Hangzhou, Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

杭州市第一人民医院

具体地址:

浙江省杭州市上城区浣纱路261号

Institution
hospital:

Hangzhou First People's Hospital

Address:

261 Huansha Road, Shangcheng District, Hangzhou, Zhejiang

经费或物资来源:

杭州市第一人民医院

Source(s) of funding:

Hangzhou First People's Hospital

研究疾病:

围术期神经认知障碍  

Target disease:

perioperative neurocognitive disorders

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本项目通过在老年病人胸腔镜手术中复合使用深层前锯肌平面阻滞技术,以降低围手术期应激反应,缓解手术后疼痛,并达到降低老年病人术后认知功能障碍发生的目标。从而提高老年病人围手术期安全、促进老年病人术后康复、提升老年病人生活质量,这也是加速康复外科(ERAS)理念在临床医疗工作中的体现。  

Objectives of Study:

In this project, the deep serserus anterior plane block technique was combined in thoracoscopic surgery in elderly patients to reduce perioperative stress response, relieve postoperative pain, and achieve the goal of reducing postoperative cognitive dysfunction in elderly patients. Thus, it can improve perioperative safety, promote postoperative rehabilitation and improve the quality of life of elderly patients, which is also the embodiment of the concept of Accelerated Rehabilitation surgery (ERAS) in clinical medical work.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.患有可导致认知功能下降的神经系统疾病如:帕金森、血管源性痴呆、脑出血、脑肿瘤、肝性脑病等; 2.有认知功能疾病病史(如脑出血、滥用药物史、颅内肿瘤、脑炎脑外伤等); 3.因视力障碍、听力障碍及肢体功能障碍等原因不能配合完成心理学测试; 4.有先天性智力障碍或精神病史; 5.已知有引起痛觉过敏或痛觉异常疾患或难治性癌痛的患者; 6.文盲。

Exclusion criteria:

1. Suffering from Nervous system disease that may lead to cognitive decline, such as Parkinson's disease, vascular dementia, cerebral hemorrhage, brain tumor, Hepatic encephalopathy, etc; 2. Have a history of cognitive function disorders (such as cerebral hemorrhage, drug abuse, intracranial tumors, encephalitis, and traumatic brain injury); 3. Unable to cooperate in completing the psychological test due to Visual impairment, hearing impairment, limb dysfunction and other reasons; 4. Have a history of congenital intellectual impairment or mental illness; 5. Patients known to cause Hyperalgesia or pain disorders or refractory cancer pain; 6. Illiteracy.

研究实施时间:

Study execute time:

From 2021-10-01 00:00:00 To 2022-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-10-20 00:00:00 To 2022-06-30 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

33

Group:

control group

Sample size:

干预措施:

局部浸润

干预措施代码:

Intervention:

local infiltration

Intervention code:

组别:

试验组

样本量:

33

Group:

experimental group

Sample size:

干预措施:

深层前锯肌阻滞

干预措施代码:

Intervention:

Deep anterior serratus block

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

杭州 

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

杭州市第一人民医院 

单位级别:

三甲 

Institution
hospital:

Hangzhou First People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

蒙特利尔认知评估量表

指标类型:

主要指标

Outcome:

Montreal Cognitive Assessment Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛视觉模拟量表

指标类型:

主要指标

Outcome:

The Visual Analogue Scale (VAS)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生命体征

指标类型:

次要指标

Outcome:

Vital signs

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血气分析

指标类型:

次要指标

Outcome:

arterial blood gas

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脑电双频指数

指标类型:

次要指标

Outcome:

BIS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

氧化应激

指标类型:

次要指标

Outcome:

oxidative stress

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血清

组织:

Sample Name:

blood serum

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

课题研究者采用SPSS随机数字法分组

Randomization Procedure (please state who generates the random number sequence and by what method):

The subject researcher uses SPSS random number method to group

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

不采用盲法,随机对照研究

Blinding:

No blind, randomized controlled study was used

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台 http://www.medresman.org.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Clinical Trial Management Public Platform http://www.medresman.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

纸质的病例记录表本研究设计者自行设计 ResMan平台管理数据, 但目前实验还在统计撰写文章,发表文章后共享数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Vital signs were monitored by ECG monitor, BIS entropy of anesthesia depth was monitored by EEG monitor, MOCA scale and VAS score were evaluated by professionals, and oxidative stress factors were tested by professionals in the laboratory. The final overall management of data, SPSS analysis of statistical results

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-02-28 09:15:18